Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-14

Clinical Trial Update: Melatonin-Micronutrients for Osteopenia Treatment Study [Phase 1]

View source ↗

Summary

This Phase 1 study evaluating melatonin with micronutrients for osteopenia/osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Duquesne University | Conditions: Osteoporosis, Osteopenia | Phase 1 | Status: COMPLETED